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Rare Anaemias (RA) are a group of Rare Diseases
(RD) with prevalence, in Europe, less than 5 per 10.000
individuals. Major forms of RAs require red blood cell
transfusions, iron chelation, splenectomy, and/or in very
severe cases, bone marrow transplantation, as main ther-
apeutic options. Beta-thalassaemia major is predominant
in Italy and Cyprus, and sickle cell disease (SCD) in
African population. During the last 30 years, SCD is
increasing in Europe due to African immigration, lead-
ing to an important impact on health care burden in
several countries. Preventive programs, aiming to epide-
miological control, and improvement of diagnosis and
clinical management of major RA, are crucial for
decreasing the affected birth rate and achieving an effi-
cient balance between morbidity and patient’s life expec-
tancy. Since 2003, the European Network for Rare and
Congenital Anaemias (ENERCA) has taken an active
role for improving this situation by the following
actions: a) the identification of Centres of Expertise on
RAs in Europe according to the recommendations of
ENERCA White Book b) the promotion of best clinical
and laboratory practices by the publication of ENERCA
recommendations c) the improving of continuous medi-
cal education, by organising topic-specific training
courses, workshops and symposia, e) the empowerment
of patients, by cooperation with Patient’s Associations,
and co-organizing a bi-annual European Symposium on
RAs with interactive patients-health professionals
sessions. In September 2013, a new phase of the project
called e-ENERCA has started with the aim to provide,
patients and professionals with e-Health tools for assure
the same access to health services in RAs across Europe,
independently from the country of practise and origin of
the patients. e-Health services will be developed through
the set-up of three different e-platforms endorsed
by ENERCA website (http://www.enerca.org) :
1) e-Registry, a Pan European registry of RAs for gath-
ering patient’s data necessary to achieve the required
sample size for epidemiological surveillance and clini-
cal research 2) e-Learning , a teaching platform for
the dissemination of knowledge, continuous medical
education, and best practices awareness and promotion
through Internet, and 3) e-Medicine , a platform to
provide, at distance, expertise (telexpertise) and diag-
nostic facilities (telediagnosis), avoiding, when possible,
the need of travelling. Finally, e-ENERCA will also
promote the recognition of the previously identified
Centres of Expertise in RAs (White Book) by the
national health authorities, a mandatory condition for
ENERCA final recognition as European Reference
Network in Rare Anaemias (RA-ERN).
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